Leading manufacturers like Johnson & Johnson, BD, Baxter, Edwards Lifesciences, Abbott Laboratories, ResMed, Medtronic, and others participate as application reviewers, mentors, judges, or sponsors
In 2017, MedTech Innovator will be at the Medtech Strategist Innovation Summit in Dublin, Ireland; the Wilson Sonsini Medical Device Conference in San Francisco, CA; and AdvaMed 2017 in San Jose, CA
Providers like UCLA Health, Mayo Clinic, and Providence participate as application reviewers and judges and give critical feedback on topics like healthcare economics, customer requirements, integration issues, and more
Active investors like RCT Ventures, Aphelion Capital, NEA, Life Science Angels, Healthtech Capital, Band of Angels, and others participate as application reviewers, mentors, and judges
AdvaMed Accel and AdvaMed 2017 have partnered with MedTech Innovator to provide best-in-class start-ups access to a virtual accelerator and to support AdvaMed members developing innovative and transformational medical technologies. AdvaMed represents 80 percent of medtech firms in the U.S., producing nearly 90 percent of the health care technology purchased in the U.S. each year.
Experts provide critical feedback to MedTech Innovator companies from leading service providers like Triple Ring, NuSil, Shay Glenn LLP, Wilson Sonsini Goodrich & Rosati, Axon Lawyers, S2N Health, Emerson Consultants, ICON plc, Silicon Valley Bank, Square One Bank, Gravitas Healthcare, and more
In 2017, MedTech Innovator and its partners will give out over $500K in cash prizes, scholarships, and in-kind awards. The competition includes several rounds where companies gain increasing amounts of exposure to industry leaders including through online application reviews, in-person pitch sessions, and audience competitions at three conferences.
MedTech Innovator 100 – 100 companies that embody MedTech Innovator’s mission to transform healthcare were invited to pitch at one of 11 in-person regional pitch events, where they had the opportunity to present to judges including investors, providers, and senior executives from leading medtech companies such as Johnson & Johnson, BD, Baxter, and many others. Additionally, MedTech Innovator 100 companies will each receive 1 complimentary registration to the AdvaMed Accel Leadership Seminar on September 25th in San Jose, CA. The seminar, which takes place on the first day of The MedTech Conference, provides companies with access to exclusive programming featuring leading business development executives and investors. All companies in the MedTech Innovator 100 are provided with review summaries from the MedTech Innovator team and are featured in the MedTech Innovator Annual Industry Report.
MedTech Innovator Showcase – 50 companies were selected from the MedTech Innovator 100 to present in the MedTech Innovator Showcase at The MedTech Conference. The MedTech Innovator Showcase is an on-stage interactive program on the main exhibit floor, which highlights the most innovative companies in sector-based sessions and is moderated by leading corporate executives and investors. All 50 Showcase companies will receive a single full scholarship to attend The MedTech Conference, as well as the invitation-only CEO Networking Dinner. Additionally, MedTech Innovator Showcase companies receive a dedicated space for one-on-one meetings over the three day conference, as well as enhanced profiles in the conference partnering website and in a published booklet distributed at the conference.
MedTech Innovator Accelerator – 20 companies have received a place in the MedTech Innovator Accelerator, a 4-month virtual program from June – September. Accelerator companies have an unprecedented opportunity to receive continual in-depth, customized mentorship from senior leaders in the medtech industry. The accelerator commences with a 3-day Kick-Off event in San Francisco, CA in June that includes exclusive networking, workshops, and pitching with investors, manufacturers, providers, and customers. All 20 Accelerator companies receive complimentary registration to the WSGR Medical Device Conference where they have opportunities to showcase their company and compete to present for a $25K Value Award and a profile in the MedTech Strategist. The Accelerator program concludes with all 20 companies participating in the Accel Leadership Seminar, the MedTech Innovator Showcase, and an opportunity to compete to present in the finals at The MedTech Conference.
Chronic Disease Management – Innovations in treating and monitoring chronic conditions, such as heart and lung disease, diabetes, obesity, oncology, hypertension, arthritis / osteoarthritis, etc.
Examples include preventing acute events at home or in the hospital; reducing ER visits and hospital utilization; preventing readmissions; improving adherence and compliance; lifestyle management; patient empowerment
Cognitive Devices & Platforms – Solutions that enhance connectivity in healthcare by leveraging big data, predictive analytics, AI, blockchain, or the Internet of Things.
Examples include hardware and software for medical device connectivity; Internet of Things in the Hospital; connected medical devices; device registries; clinical trial registration and recruitment; clinical decision support; technologies or services that enable exchange of information; medical device and wireless security
Consumer Healthcare – Technologies or platforms that engage or empower the healthcare consumer.
Examples include mobile apps; personal health tracking tools; wearables; patient empowerment and wellness; education; platforms that reduce the complexity of the healthcare ecosystem, like pricing transparency, provider selection, and benefits information
Healthcare Efficiency & Cost Reduction – Innovative services and solutions for improving the efficiency and coordination of care and lowering the cost burden of healthcare.
Examples include platforms for hospital administration and inventory management; billing accuracy and claims management; payer solutions; enabling care transitions to lowest cost settings; care coordination and care transitions management; acute care & accountable care activities; interoperability of the electronic medical record
Infectious Disease Management – Innovations in infectious disease prevention, diagnosis, treatment, and tracking.
Examples include innovative infection prevention tools, devices and monitoring technologies; surveillance and reporting; reduced infections, needlestick & exposure hazards; effective and consistent decontamination and sterilization of medical devices; near-patient testing; diagnostics performed at hospital bedside, provider office, retail settings, such as the minute clinic, etc.; non-invasive diagnostics; rapid diagnostics, especially for malaria, ebola, TB and other global health challenges
Next-Gen Surgical – Devices and software that advance current surgical techniques.
Examples include interventional therapies; minimally-invasive therapies; non-invasive therapies; surgical imaging and diagnostic tools; robotics; moving from inpatient to outpatient surgical procedures; neuromodulation; surgical training & AR / VR tools
Patient Safety & Satisfaction – Technologies that deliver improved patient value through advances in patient safety, satisfaction, and quality of care.
Examples include prevention of never events, adverse events & medication errors; medication safety & assurance; improved time to diagnosis; reduced missed diagnoses; reduced hospital readmissions; patient management solutions; decreased wait times; improved patient to caregiver communication; health education; smart rooms
Population Health – Tools that improve patient engagement, decision making and outcomes tracking.
Examples include solutions for personalization and portability of the electronic medical record; predictive analytic models; clinical trial recruitment and selection; mobile apps as devices; wearable technologies and sensors; at-home diagnostics; patient-centered medical home; community and caregiver engagement
Precision Medicine & Personalized Medicine – Technologies that utilize an aspect of personalized medicine.
Examples include next-generation sequencing, proteomics, metabolomics; digital biomarkers; device-on-demand; 3D printed devices; next-generation point of care diagnostics
Technology-Enabled Services – Services that leverage technology-based tools to improve existing treatments or care pathways as well as facilitate new business models driving improvements in patient care.
Examples include telehealth / telemedicine; remote patient monitoring; asynchronous care delivery; services on demand
Paul is MedTech Innovator’s CEO. He founded and has managed MedTech Innovator as a program within RCT Ventures for the past four years. In 2016, with the financial support of RCT and other sponsors, Paul left to run MedTech Innovator as a stand-alone company. He has spent the last 11 years as Managing Director for RCT Ventures, the investment arm of Research Corporation Technologies, Inc.
Jennifer McCaney serves as MedTech Innovator’s Director. She is a Visiting Assistant Professor at the UCLA David Geffen School of Medicine. Jennifer oversees the MedTech Innovation Program at UCLA and holds a Lecturer position at the Anderson School of Management, where she teaches courses on disruptive technologies in health care and MedTech innovation.
Kathryn Zavala is Program Director for MedTech Innovator. She earned her PhD in Molecular, Cell and Developmental Biology from UCLA. Kathryn was a Technology Fellow at the UCLA Office of Intellectual Property, where she assisted with the commercialization of university technologies.
Ashley is the Vice President of Business Development and Communications for MedTech Innovator. She previously served as the vice president of Membership and Business Development at the Advanced Medical Technology Association (AdvaMed).
She is a graduate of the University of Georgia’s Grady School of Journalism and has a master’s degree in public affairs from George Washington University.
Jenell Paul-Robinson, MSN, RN is Vice President, Clinical Value and Provider Relations at MedTech Innovator. She received her master’s degree in Nursing Administration from UCLA. Jenell brings over 20 years clinical nursing, strategic sourcing, and hospital organization value analysis experience to the team. She served on several national supply chain and academic medical center value analysis professional committees.
Johnny is a Pharmacist by training. He spent 10 years working in the retail pharmacy setting with CVS and Target. Johnny is currently an Executive MBA candidate at the UCLA Anderson School of Management, where he is focusing on Entrepreneurship and Technology Leadership. His current focus area is pharmacy innovation and consumer directed healthcare. Johnny earned a PharmD. from the University of Michigan, College of Pharmacy and a B.S. in Biochemistry and Molecular Biology from Michigan State University.